DFO
Showing 1 - 25 of 76
Multiple Myeloma, Plasma Cell Myeloma Trial in San Francisco (drug, procedure, other)
Not yet recruiting
- Multiple Myeloma
- Plasma Cell Myeloma
- Zirconium Zr 89-DFO-YS5
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 26, 2023
Prostate Cancer Trial in New York (89Zr- DFO-MSTP2109A, 89Zr DFO-MSTP2109A)
Active, not recruiting
- Prostate Cancer
- 89Zr- DFO-MSTP2109A
- 89Zr DFO-MSTP2109A
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 1, 2023
Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)
Available
- Clear Cell Renal Cell Carcinoma
- 89Zr-DFO-girentuximab
-
Los Angeles, CaliforniaUCLA
Oct 12, 2023
Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer Trial in Amsterdam (89Zr-DFO*-trastuzumab PET scan)
Recruiting
- Breast Cancer
- +5 more
- 89Zr-DFO*-trastuzumab PET scan
-
Amsterdam, Noord-Holland, NetherlandsAmsterdamUMC
Jul 12, 2023
Large B-cell Lymphoma, DLBCL Trial in New York (89Zr-DFO-REGN3767, PET/CT)
Recruiting
- Large B-cell Lymphoma
- DLBCL
- 89Zr-DFO-REGN3767
- PET/CT
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 3, 2022
Advanced Solid Tumor, Metastatic Solid Tumor Trial (89Zr?DFO?REGN5054, cemiplimab)
Not yet recruiting
- Advanced Solid Tumor
- Metastatic Solid Tumor
- (no location specified)
Aug 5, 2022
Amyotrophic Lateral Sclerosis Trial (89Zr-DFO-AP-101)
Not yet recruiting
- Amyotrophic Lateral Sclerosis
- (no location specified)
Jul 26, 2023
Lung Cancer, Colorectal Cancer Trial in Saskatoon (50 mg 89Zr-DFO-Nimotuzumab, 1 mg 89Zr-DFO-Nimotuzumab)
Recruiting
- Lung Cancer
- Colorectal Cancer
- 50 mg 89Zr-DFO-Nimotuzumab
- 1 mg 89Zr-DFO-Nimotuzumab
-
Saskatoon, Saskatchewan, CanadaRoyal University Hospital
May 18, 2022
Subjects With Diabetes and DFU With a Suspicion of DFO Trial in Paris (Bedside blind bone biopsy procedure)
Not yet recruiting
- Subjects With Diabetes and DFU With a Suspicion of DFO
- Bedside blind bone biopsy procedure
-
Paris, FranceBichat - Claude Bernard Hospital
Sep 28, 2023
Esophagogastric Cancer Trial in New York (89Zr-DFO-trastuzumab, PET imaging)
Active, not recruiting
- Esophagogastric Cancer
- 89Zr-DFO-trastuzumab
- PET imaging
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 7, 2021
Prostate Cancer Trial in New York (89Zr-DFO-huJ591)
Active, not recruiting
- Prostate Cancer
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Feb 28, 2022
Diabetic Foot Ulcers, Osteomyelitis Trial in Dallas (DFU)
Recruiting
- Diabetic Foot Ulcers
- Osteomyelitis
- DFU
-
Dallas, Texas
- +1 more
Jun 14, 2022
Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco (drug, biological, procedure)
Recruiting
- Prostate Cancer
- Metastatic Castration-resistant Prostate Cancer
- 89Zr-DFO-YS5
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 29, 2022
Metastatic Solid Tumor Trial in Groningen (89Zr-DFO-REGN3767, Cemiplimab)
Recruiting
- Metastatic Solid Tumor
- 89Zr-DFO-REGN3767
- Cemiplimab
-
Groningen, NetherlandsUniversity Medical Center Groninen
Jan 24, 2022
Advanced PD-L1 Positive Malignancies Trial in New York (89Zr?DFO?REGN3504)
Terminated
- Advanced PD-L1 Positive Malignancies
-
New York, New York
- +1 more
Feb 7, 2022
Siderophores for Imaging Infection Using 68Ga-DFO
Recruiting
- Vascular Graft Infection
- PET-CT scan
-
London, United KingdomKings College London and Guy's and St Thomas' Hospital PET Centr
Mar 16, 2022
Leptomeningeal Metastases Trial in United States (Deferoxamine (DFO))
Recruiting
- Leptomeningeal Metastases
- Deferoxamine (DFO)
-
Basking Ridge, New Jersey
- +6 more
Jun 27, 2022
Rheumatoid Arthritis Trial in San Francisco (89Zr-DFO-CZP)
Suspended
- Rheumatoid Arthritis
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jun 7, 2022
Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- +2 more
- (no location specified)
May 14, 2023
Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))
Completed
- Thalassemia
- Iron Overload
- Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
-
Oakland, CaliforniaCHRCO
Jul 20, 2021
Multiple Myeloma Trial in New York (drug, device, other)
Completed
- Multiple Myeloma
- 89Zr-daratumumab
- +2 more
-
New York, New YorkMemorial Slaon-Kettering Cancer Center
Jul 9, 2021
Open Versus Closed Wedge Distal Femoral Varus Osteotomy for
Completed
- Valgus Malalignment of the Knee
- Data collection from routine medical records
-
Basel, Basel Stadt, SwitzerlandClinic for Orthopaedics and Traumatology, University Hospital ba
Mar 14, 2022